Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Future developments in implantable cardioverter defibrillators: the optimal device

D J Callans1, M E Josephson

  • 1Clinical Electrophysiology Laboratories, Hospital of the University of Pennsylvania, Philadelphia.

Progress in Cardiovascular Diseases
|November 1, 1993
PubMed
Summary

Sudden cardiac death (SCD) is a major mortality cause, often from ventricular tachyarrhythmias. Implantable cardioverter-defibrillators (ICDs) effectively prevent SCD, with future devices promising further improvements.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Comparison between three-dimensional electro-anatomical mapping and conventional mapping in the ablation of atrial tachycardias].

Archives des maladies du coeur et des vaisseaux·2005
Same author

Subclinical pulmonary vein narrowing after ablation for atrial fibrillation.

Heart (British Cardiac Society)·2005
Same author

Isolation of atrial fibrillation to a pulmonary vein.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2004
Same author

Inpatient or outpatient initiation of antiarrhythmic medications: why the controversy?

Heart disease (Hagerstown, Md.)·2002
Same author

Clinical cardiac electrophysiology fellowship teaching objectives for the new millennium.

Journal of cardiovascular electrophysiology·2002
Same author

Ventricular Tachycardia in Ebstein's Anomaly.

Circulation·2001

Area of Science:

  • Cardiology
  • Medical Devices
  • Sudden Cardiac Death

Background:

  • Sudden cardiac death (SCD) remains a leading cause of mortality, primarily due to ventricular tachyarrhythmias in patients with structural heart disease.
  • Current primary prevention strategies for SCD have shown limited success, highlighting the need for effective interventions.

Purpose of the Study:

  • To review the effectiveness of current treatments for SCD survivors, focusing on implantable cardioverter-defibrillators (ICDs).
  • To discuss the future directions and desired characteristics of optimal ICDs for improved patient outcomes and broader application.

Main Methods:

  • Review of existing literature on SCD, its causes, and treatment strategies.
  • Analysis of the efficacy of antiarrhythmic drugs, endocardial resection, and ICDs in SCD management.

Related Experiment Videos

  • Discussion of technological advancements and future requirements for ideal ICD systems.

    • Main Results:

    • Implantable cardioverter-defibrillators (ICDs) are highly effective in preventing recurrent sudden cardiac death from ventricular tachyarrhythmias.
    • Widespread ICD adoption depends on demonstrating improved total mortality, cost-effectiveness, and device enhancements.

    Conclusions:

    • Future ICDs should feature non-thoracotomy lead placement, subpectoral generator placement, multiprogrammable tiered therapy, and enhanced diagnostic and data storage capabilities.
    • Continued technological innovation is crucial for developing ideal ICDs, offering optimism for reducing SCD mortality.